Position
Squarepoint Ops LLC in Oruka Therapeutics, Inc.
Back to the book · All holders of ORKA
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark $458.4K$30.31 → $49.05
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 27.7K | $838.7K | — | — | — | 0.0% |
| Q1 2026 | 24.5K | $1.2M | $49.05 | $458.4K | −$97.2K | 0.0% |